| Arrows Pediatric Therapies, Llc | |
|
23 Griffin Rd, Londonderry, NH 03053-3944 | |
| (631) 741-6593 | |
| Not Available |
| Full Name | Arrows Pediatric Therapies, Llc |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 23 Griffin Rd, Londonderry, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629743349 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Arrows Pediatric Therapies, Llc 23 Griffin Rd, Londonderry, NH 03053-3944 Ph: (631) 741-6593 | Arrows Pediatric Therapies, Llc 23 Griffin Rd, Londonderry, NH 03053-3944 Ph: (631) 741-6593 |
News Archive
Diagnosing a rare medical condition is difficult. Identifying a treatment for it can take years of trial and error. In a serendipitous intersection of research expertise, an ill patient in this case a child and innovative technology, Bachmann-Bupp Syndrome has gone from a list of symptoms to a successful treatment in just 16 months.
Numerous experts from The Children's Hospital of Philadelphia will be addressing their colleagues at this year's annual meeting of the American Academy of Pediatrics on topics as varied as vaccine education, fetal surgery, sudden cardiac arrest, and sports injuries, among others.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
› Verified 1 days ago
Janelle L Carter, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Commons Dr # F, Suite 38, Londonderry, NH 03053 Phone: 603-437-3330 Fax: 603-437-0431 | |
Nicole Bernier, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 275 Mammoth Rd, Londonderry, NH 03053 Phone: 978-204-9541 | |
Nicole Sheaff, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1f Commons Drive, Suite 38, Londonderry, NH 03053 Phone: 603-437-3330 Fax: 603-437-0431 | |
Courtney Nicole Vargas, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Commons Dr # F, Suite 38, Londonderry, NH 03053 Phone: 603-437-3330 Fax: 603-437-0431 | |
Barbara Bailey, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Commons Dr # F, Suite 38, Londonderry, NH 03053 Phone: 603-437-3330 | |
Doreen Leslie Harmon, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 718 Lucas Rd, Londonderry, NH 03053 Phone: 603-434-3960 | |
Jenelle Byerly, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6a Kitty Hawk Lndg, Londonderry, NH 03053 Phone: 603-432-6920 |